Search En menu ClientConnect
Top 5 search results See all results Advanced search
Top searches
Most visited pages


    € 130,000,000
    France : € 19,500,000
    Austria : € 26,000,000
    Germany : € 32,500,000
    Belgium : € 52,000,000
    Industry : € 130,000,000
    Signature date(s)
    22/11/2010 : € 19,500,000
    22/11/2010 : € 26,000,000
    22/11/2010 : € 32,500,000
    22/11/2010 : € 52,000,000

    Summary sheet

    Release date
    7 July 2010
    Signed | 22/11/2010
    Project name
    Promoter - financial intermediary
    Healthcare Software RDI RSFF

    Agfa-Gevaert N.V.

    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    To be determined.
    To be determined.

    The project concerns the promoter’s investment in research, development and innovation (RDI) for healthcare IT and imaging technology.

    The project aims at the development and market launch of new products in three different areas: (i) Hospital Information Systems (HIS, the equivalent of an enterprise IT system for hospitals); (ii) Picture Archiving and Communication Systems (PACS) for applications in medical imaging in radiology and cardiology; and (iii) digital radiography (i.e. the digitalisation of analogue medical images). It includes the RDI activities in the period 2010 up to and including 2013, when the majority of the new products are expected to be launched on the market.

    Environmental aspects

    R&D activities included in the project will not materially change current R&D practice and will be carried out within existing facilities. An Environmental Impact Assessment (EIA) is, therefore, not required by EU Directive 97/11; this will, however, be verified during appraisal. Compliance of R&D activities with relevant EU legislation will be also be verified during appraisal.

    The promoter is a private company not operating in the Utilities sector, and is thus not covered by EU Directives on procurement. Procedures followed will be verified during appraisal.


    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications